Found 171 results
Filters: Author is Muyldermans, Serge  [Clear All Filters]
Yardehnavi, N., Behdani M., Bagheri K. Pooshang, Mahmoodzadeh A., Khanahmad H., Shahbazzadeh D., Habibi-Anbouhi M., Ghassabeh G. Hassanzade, and Muyldermans S., "A camelid antibody candidate for development of a therapeutic agent against Hemiscorpius lepturus envenomation.", FASEB J, 2014 Jun 2.
Subedi, S., Moonens K., Romão E., Lo A., Vandenbussche G., Bugaytsova J., Muyldermans S., Borén T., and Remaut H., "Expression, purification and X-ray crystallographic analysis of the Helicobacter pylori blood group antigen-binding adhesin BabA.", Acta Crystallogr F Struct Biol Commun, vol. 70, issue Pt 12, pp. 1631-5, 2014 Dec 01.
Pardon, E., Laeremans T., Triest S., Rasmussen S. G. F., Wohlkonig A., Ruf A., Muyldermans S., Hol W. G. J., Kobilka B. K., and Steyaert J., "A general protocol for the generation of Nanobodies for structural biology.", Nat Protoc, vol. 9, issue 3, pp. 674-93, 2014 Mar.
Evazalipour, M., D'huyvetter M., Tehrani B. Soltani, Abolhassani M., Omidfar K., Abdoli S., Arezumand R., Morovvati H., Lahoutte T., Muyldermans S., et al., "Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer.", Contrast Media Mol Imaging, vol. 9, issue 3, pp. 211-20, 2014 May-Jun.
De Meyer, T., Eeckhout D., De Rycke R., De Buck S., Muyldermans S., and Depicker A., "Generation of VHH antibodies against the Arabidopsis thaliana seed storage proteins.", Plant Mol Biol, vol. 84, issue 1-2, pp. 83-93, 2014 Jan.
Hendrickx, M. L. V., Zatloukalova M., Hassanzadeh-Ghassabeh G., Muyldermans S., Gils A., and Declerck P. J., "Identification of a novel, nanobody-induced, mechanism of TAFI inactivation and its in vivo application.", J Thromb Haemost, vol. 12, issue 2, pp. 229-36, 2014 Feb.
Lemaire, M., D'Huyvetter M., Lahoutte T., Van Valckenborgh E., Menu E., De Bruyne E., Kronenberger P., Wernery U., Muyldermans S., Devoogdt N., et al., "Imaging and radioimmunotherapy of multiple myeloma with anti-idiotypic Nanobodies.", Leukemia, vol. 28, issue 2, pp. 444-7, 2014 Feb.
Hendrickx, M. L. V., Zatloukalova M., Hassanzadeh-Ghassabeh G., Muyldermans S., Gils A., and Declerck P. J., "In vitro and in vivo characterisation of the profibrinolytic effect of an inhibitory anti-rat TAFI nanobody.", Thromb Haemost, vol. 111, issue 5, pp. 824-32, 2014 May 5.
Huang, Y., Nokhrin S., Hassanzadeh-Ghassabeh G., Yu C. H., Yang H., Barry A. N., Tonelli M., Markley J. L., Muyldermans S., Dmitriev O. Y., et al., "Interactions between Metal-binding Domains Modulate Intracellular Targeting of Cu(I)-ATPase ATP7B, as Revealed by Nanobody Binding.", J Biol Chem, vol. 289, issue 47, pp. 32682-93, 2014 Nov 21.
Zheng, F., Put S., Bouwens L., Lahoutte T., Matthys P., Muyldermans S., De Baetselier P., Devoogdt N., Raes G., and Schoonooghe S., "Molecular imaging with macrophage CRIg-targeting nanobodies for early and preclinical diagnosis in a mouse model of rheumatoid arthritis.", J Nucl Med, vol. 55, issue 5, pp. 824-9, 2014 May.
Li, H., Sun Y., Elseviers J., Muyldermans S., Liu S., and Wan Y., "A nanobody-based electrochemiluminescent immunosensor for sensitive detection of human procalcitonin.", Analyst, vol. 139, issue 15, pp. 3718-21, 2014 Aug 7.
De Meyer, T., Muyldermans S., and Depicker A., "Nanobody-based products as research and diagnostic tools.", Trends Biotechnol, vol. 32, issue 5, pp. 263-70, 2014 May.
Patris, S., De Pauw P., Vandeput M., Huet J., Van Antwerpen P., Muyldermans S., and Kauffmann J-M., "Nanoimmunoassay onto a screen printed electrode for HER2 breast cancer biomarker determination.", Talanta, vol. 130, pp. 164-70, 2014 Dec.
D'huyvetter, M., Xavier C., Caveliers V., Lahoutte T., Muyldermans S., and Devoogdt N., "Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer.", Expert Opin Drug Deliv, vol. 11, issue 12, pp. 1939-54, 2014 Dec.
Cardoso, F. Miguel, Ibañez L. Itatí, Van den Hoecke S., De Baets S., Smet A., Roose K., Schepens B., Descamps F. J., Fiers W., Muyldermans S., et al., "Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge.", J Virol, vol. 88, issue 15, pp. 8278-96, 2014 Aug.
Massa, S., Xavier C., De Vos J., Caveliers V., Lahoutte T., Muyldermans S., and Devoogdt N., "Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging.", Bioconjug Chem, vol. 25, issue 5, pp. 979-88, 2014 May 21.
De Vos, J., Mathijs I., Xavier C., Massa S., Wernery U., Bouwens L., Lahoutte T., Muyldermans S., and Devoogdt N., "Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1.", Mol Imaging Biol, vol. 16, issue 5, pp. 690-8, 2014 Oct.
Chaikuad, A., Keates T., Vincke C., Kaufholz M., Zenn M., Zimmermann B., Gutiérrez C., Zhang R-G., Hatzos-Skintges C., Joachimiak A., et al., "Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies.", Biochem J, vol. 459, issue 1, pp. 59-69, 2014 Apr 1.
D'huyvetter, M., Vincke C., Xavier C., Aerts A., Impens N., Baatout S., De Raeve H., Muyldermans S., Caveliers V., Devoogdt N., et al., "Targeted radionuclide therapy with A 177Lu-labeled anti-HER2 nanobody.", Theranostics, vol. 4, issue 7, pp. 708-20, 2014.
Jovčevska, I., Zupanec N., Kočevar N., Cesselli D., Podergajs N., Stokin C. Limbaeck, Myers M. P., Muyldermans S., Ghassabeh G. Hassanzade, Motaln H., et al., "TRIM28 and β-Actin Identified via Nanobody-Based Reverse Proteomics Approach as Possible Human Glioblastoma Biomarkers.", PLoS One, vol. 9, issue 11, pp. e113688, 2014.
Gad, W., Ben-Abderrazek R., Wahni K., Vertommen D., Muyldermans S., Bouhaouala-Zahar B., and Messens J., "Wheat germ in vitro translation to produce one of the most toxic sodium channel specific toxins.", Biosci Rep, vol. 34, issue 4, 2014 Jul 29.